ClassID:

170916

G01N2800/7085 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Mechanisms involved in disease identification (Intracellular) signaling and trafficking pathways; Metabolic pathways Lipogenesis or lipolysis, e.g. fatty acid metabolism

Recent Application in this class:
#1
20260072044
2026-03-12

Pulse Stable Tracer Methods for Detection of Short-Chain Fatty Acids

#2
20230251278
2023-08-10

ACQUISITION METHOD OF VALUE RELATING TO TRIGLYCERIDE METABOLIC CAPACITY, PRESENTATION METHOD OF DISEASE INFORMATION, PRESENTATION METHOD OF DISEASE DIFFERENTIATION INFORMATION, PRESENTATION METHOD OF THERAPY EFFICACY INFORMATION, PRESENTATION METHOD OF THERAPEUTIC EFFECT INFORMATION, TEST REAGENT AND TEST KIT

#3
20220404336
2022-12-22

COMPOSITIONS, METHODS AND USES FOR FREE FATTY ACID SCREENING OF CELLS AT SCALE

#4
20210071224
2021-03-11

Electrochemical strips for monitoring the degradation of body fat and method for preparing same

#5
20200345808
2020-11-05

NOVEL PHARMACOLOGICAL THERAPY FOR NEURONOPATHIC GAUCHER DISEASE

#6
20200340976
2020-10-29

Use of leucine-zipper protein for diagnosis or treatment of fatty liver

#7
20190302101
2019-10-03

Use of leucine-zipper protein for diagnosis or treatment of fatty liver

#8
20190231871
2019-08-01

Diagnosis and treatment of autism spectrum disorder

#9
20180207294
2018-07-26

NON-ALCOHOLIC FATTY LIVER REGULATING FACTOR 14-3-3 PROTEIN

#10
20180031585
2018-02-01

Methods and compositions for identifying non-alcoholic fatty liver disease

#11
20170319651
2017-11-09

Pharmacological therapy for neuronopathic Gaucher disease

#12
20170315133
2017-11-02

METHOD OF DIAGNOSING AND TREATING BRAIN ENDOTHELIAL INFLAMMATION RELATED DISEASE

#13
20170138967
2017-05-18

METABOLICS BIOMARKER FOR NAFLD AND METHODS OF USE

#14
20160367537
2016-12-22

COMPOSITIONS AND METHODS FOR THE TREATMENT AND MANAGEMENT OF STEATOSIS IN HUMAN LIVER

#15
20160356798
2016-12-08

BIOMARKERS OF DE NOVO LIPOGENESIS AND METHODS USING THE SAME

#16
20160069879
2016-03-10

METHOD FOR MEASURING ALPHA-GALACTOSIDASE CONCENTRATION

#17
20150132834
2015-05-14

Method for removal of triglycerides in lipoproteins other than low-density lipoproteins

#18
20140065132
2014-03-06

Diagnosis and treatment of autism spectrum disorder

#19
20120231470
2012-09-13

METHODS AND SYSTEMS ASSOCIATED WITH DETECTION OF FATTY ACID ELONGATION IN A CELL